Skip to main content

Share story

Science

Scientists Create Novel Organism With Primitive Nervous System

A scientific image of a biobot highlighted to show off hairlike cells on its exterior Image: Primary
Researchers at Tufts University and the Wyss Institute created neurobots by implanting clusters of neural precursor cells from African clawed frog embryos into developing xenobots. The implanted cells matured into neurons that extended axons and dendrites throughout the structures and formed primitive neural networks. The neurobots were made from precursor skin cells that spontaneously form spherical shapes covered in cilia. The neurons showed hallmark features of nervous systems including protein markers for synapses. Calcium imaging confirmed that the neurons were electrically active and functioning in simple networks. Compared with non-neural xenobots the neurobots grew larger and more elongated and displayed complex repeating movement patterns rather than simple paths. Exposure to pentylenetetrazole a drug that affects brain activity altered the movement of neurobots differently than it did non-neural biobots. The researchers also found activation of genes involved in visual perception. The findings were reported recently in Advanced Science. The work was led by Michael Levin and Haleh Fotowat. It examined how neurons organize on their own in a novel biological context without evolutionary shaping. The study used cells from early Xenopus laevis embryos and observed the bots survive on stored nutrients for about nine to ten days.
Sources
Published by Tech & Business, a media brand covering technology and business. This story was sourced from now.tufts.edu and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Capital
Capital

Nominal raises $240 million at a $3 billion valuation

Nominal has raised $240 million at a $3 billion valuation, triple its valuation in a funding round earlier this year, Bloomberg reports. The startup builds software to make manufacturing more efficient.

Capital Products
Capital Products

Onodrim raises $300M to acquire European defence and industrial suppliers

Amsterdam-based Onodrim Industries has raised $300M in a round led by Lux Capital, valuing the defence group at $1.3bn, the company said Monday. Other investors include General Catalyst, Lakestar and Altimeter. The financing follows its €40M seed round in February.

Capital
Capital

SRTD Biotech raises €31.5 million for targeted RNA therapies

SRTD Biotech has completed an oversubscribed €31.5 million seed financing to develop RNA therapies designed to act selectively inside diseased cells. Mérieux Equity Partners led the round, with NRW.BANK and Boehringer Ingelheim Venture Fund joining as co-leads.